Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Vaxart, Inc. (VXRT) · INSIDER

Data sources

SEC Form 42h ago

House PTR2h ago

SEC 13F2h ago

Robinhood Chain2h ago

Public company

Vaxart, Inc.

VXRTCIK 0000072444

EDGAR filings Open in network

Price$0.37

1 year+12.1%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence2

VXRT · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Lobbied forevidence
TODD STRATEGY GROUPLDA Q2 2026 second quarter · MED · Aug 26, 2026

Lobbying

$120K reported · de-duplicated

2026 Q2 $60K via firms2026 Q1 $60K via firms

TODD STRATEGY GROUP$60K2026 Q1 · posted Aug 26, 2026 · MED
TODD STRATEGY GROUP$60K2026 Q2 · posted Aug 26, 2026 · MED

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.